Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients
| Autor: | Papanas, N, Tziakas, D, Chalikias, G, Floros, D, Trypsianis, G, Papadopoulou, E, Kortsaris, A, Symeonidis, G, Souliou, E, Maltezos, E, Hatseras, D |
|---|---|
| Zdroj: | In Diabetes and Metabolism 2006 32(4):344-349 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect